Journal of Surgery Concepts & Practice >

2023 , Vol. 28 >Issue 05: 420 - 424

DOI: https://doi.org/10.16139/j.1007-9610.2023.05.05

Experts forum

Prevention and control of multidrug-resistant bacteria infection in surgical patients

Expand
  • Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received date: 2023-08-02

  Online published: 2024-01-04

Fold

Abstract

The current situation of multidrug-resistant bacteria infection in surgical patients is becoming increasingly severe. Effective prevention of cross transmission of multidrug-resistant bacteria and common site infections in ICU patients is the key step. In response to the key issues in the prevention and control of multidrug-resistant bacteria infection, a comprehensive strategy is implemented. Core measures such as early recognition, preemptive isolation, active screening, and graded prevention and control are taken for patients, and targeted preventive measures for common infection sites are combined to form a detection and control system of multidrug-resistant bacteria for ICU patients. By moving forward and extrapolating to the general ward, the prevention and control system effectively reduced the incidence of multidrug-resistant bacteria colonization/infection in surgical patients.

Key words： Carbapenem-resistant Gram-negative bacteria; Intensive care unit; Infection control and prevention

Cite this article

TAN Ruoming, QU Hongping . Prevention and control of multidrug-resistant bacteria infection in surgical patients[J]. Journal of Surgery Concepts & Practice, 2023 , 28(05) : 420 -424 . DOI: 10.16139/j.1007-9610.2023.05.05

References

[1] 姚咏明, 刘峰. 外科严重感染及其并发症的防治策略[J]. 中华外科杂志, 2006, 44(9):577-580.
[1] YAO Y M, LIU F. Prevention and treatment strategies for serious surgical infections and complications[J]. Chin J Surg, 2006, 44(9):577-580.
[2] CHANG Y T, COOMBS G, LING T, et al. Epidemiology and trends in the antibiotic susceptibilities of Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010-2013[J]. Int J Antimicrob Agents, 2017, 49(6):734-739.
[3] 秦圆圆, 黄文祥, 赵罗乐, 等. 腹腔内感染478例临床分析及病原菌分布[J]. 中国感染与化疗杂志, 2018, 18(6):561-567.
[3] QIN Y Y, HUANG W X, ZHAO L L, et al. Intra-abdominal infection due to Gram-negative bacilli:an analysis of 478 cases[J]. Chin J Infect Chemother, 2018, 18(6):561-567.
[4] 潘熠平, 胡军涛, 赖洁, 等. 外科ICU重症腹腔感染的临床特征及病原菌流行病学分析[J]. 中华危重病急救医学, 2020, 32(7):792-796.
[4] PAN Y P, HU J T, LAI J, et al. Clinical characteristics and epidemiological analysis of pathogenic bacteria of severe abdominal infection in surgical intensive care unit[J]. Chin Crit Care Med, 2020, 32(7):792-796.
[5] BLOT S, ANTONELLI M, ARVANITI K, et al. Abdominal Sepsis Study (AbSeS) Group on behalf of the Trials Group of the European Society of Intensive Care Medicine. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project[J]. Intensive Care Med, 2019, 45(12):1703-1717.
[6] 丁丽, 陈佰义, 李敏, 等. 碳青霉烯类耐药革兰阴性菌联合药敏试验及报告专家共识[J]. 中国感染与化疗杂志, 2023, 23(1):80-90.
[6] DING L, CHEN B Y, LI M, et al. Expert consensus on antimicrobial synergy testing and reporting of carbapenem-resistant Gram-negative bacteria[J]. Chin J Infect Chemother, 2023, 23(1):80-90.
[7] LIU J, ZHANG L, PAN J, et al. Risk factors and molecular epidemiology of complicated intra-abdominal infections with carbapenem-resistant enterobacteriaceae: a multicenter study in China[J]. J Infect Dis, 2020, 221(Suppl 2):S156-S163.
[8] MUNOZ-PRICE L S, QUINN J P. Deconstructing the infection control bundles for the containment of carba-penem-resistant Enterobacteriaceae[J]. Curr Opin Infect Dis, 2013, 26(4):378-387.
[9] BEN-DAVID D, MASARWA S, FALLACH N, et al. National policy for carbapenem-resistant Enterobacteriaceae (CRE) clearance and discontinuation of contact precautions for CRE carriers in post-acute care hospitals in israel: impact on isolation-days and new acquisitions[J]. Clin Infect Dis, 2021, 72(5):829-835.
[10] 中华预防医学会医院感染控制分会, 中华医学会感染病学分会, 中国医院协会医院感染管理专业委员会, 等. 中国碳青霉烯耐药革兰阴性杆菌(CRO) 感染预防与控制技术指引[J]. 中华医院感染学杂志, 2019, 29(13):1921-1926.
[10] Hospital Infection Control Branch of Chinese Preventive Medicine Association, Chinese Society of Infectious Diseases, Chinese Medical Association, Chinese Hospital Association Nosocomial Infection Control Specialized Committee, et al. Technical guidelines for the prevention and control of Carbapenem-resistant Organism (CRO) infections in China[J]. Chin J Nosocomiol, 2019, 29(13):1921-1926.
[11] ZHANG H, HU S, XU D, et al. Risk factors for carba-penem resistant Gram negative bacteria (CR-GNB) carriage upon admission to the gastroenterology department in a tertiary first class hospital of China: development and assessment of a new predictive nomogram[J]. Infect Drug Resist, 2022, 15:7761-7775.
[12] LI M, WANG X, WANG J, et al. Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae: a 4-year quasi-experimental before-and-after study[J]. Antimicrob Resist Infect Control, 2019, 8:8.
[13] DAI Y, MENG T, WANG X, et al. Validation and extrapolation of a multimodal infection prevention and control intervention on carbapenem-resistant Klebsiella pneumoniae in an epidemic region: a historical control quasi-experimental study[J]. Front Med (Lausanne), 2021, 8:692813.
[14] VINCENT J L, SAKR Y, SINGER M, et al. Prevalence and outcomes of infection among patients in intensive care units in 2017[J]. JAMA, 2020, 323(15):1478-1487.
[15] ZHOU M, XIAO M, HOU R, et al. Bundles of care for prevention of ventilator-associated pneumonia caused by carbapenem-resistant Klebsiella pneumoniae in the ICU[J]. Am J Transl Res, 2021, 13(4):3561-3572.
[16] BERRíOS-TORRES S I, UMSCHEID C A, BRATZLER D W, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017[J]. JAMA Surg, 2017, 152(8):784-791.
Options
Outlines

/

〈 〉